NCT00642213

Brief Summary

Our primary goal is to study temporal trends in the incidence rate, causes, treatment, and outcome of stroke among a large biracial metropolitan population of 1,349,351, of whom 215,611 (15%) are black (2000 Census). Such data are critical for the planning, intervention, and evaluation of public health efforts to decrease the mortality and morbidity due to stroke in the United States. We have completed this goal for 1993-94, 1999, 2005, 2010 and 2015. We are in the process of collecting this data for 2020. In the 2020 study period we will also be ascertaining 3 year recurrence rates for all incident stroke events.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jul 1993

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 1993

Completed
14.7 years until next milestone

First Submitted

Initial submission to the registry

March 19, 2008

Completed
5 days until next milestone

First Posted

Study publicly available on registry

March 24, 2008

Completed
17.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2025

Completed
Last Updated

September 24, 2024

Status Verified

September 1, 2024

Enrollment Period

32 years

First QC Date

March 19, 2008

Last Update Submit

September 20, 2024

Conditions

Keywords

strokeischemicTIAhemorrhageincidencecase-fatalityrisk factorsgenetic

Outcome Measures

Primary Outcomes (1)

  • mRS

    modified Rankin Scale

    discharge or 30 days

Secondary Outcomes (1)

  • mortality

    1 year

Other Outcomes (1)

  • 2020 Stroke population mRS

    3 month, 6 month, and 1 year

Study Arms (2)

ischemic stroke sample with DNA

We prospectively collected 450(1999), 502(2005), and 512(2010) ischemic stroke patients who agreed to participate and also most provided a sample for DNA. The cohort data consists of a baseline interview, medical record abstraction and various timeframes of followup interviews from 3 months to 3 years. See website (www.gcnkss.com for data forms)

stroke data from medical record review

The second part of the study is a retrospective medical record review of all potential ischemic strokes, TIAs, and Hemorrhagic strokes in our 5 county region that occurred in all study years.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Prospective cohort:Ischemic stroke patient in 1999/2005/2010 that resides in the GCNK area. Retrospective cohorts: All stroke and TIA events occurring during the following study periods: 1993-94, 1999, 2005, 2010, 2015 and 2020. This group is ALL stroke patients of any age that resides in our 5 county region.

You may qualify if:

  • ischemic stroke
  • occurred in 1999/2005/2010
  • \>18 years old
  • resides in 5 county region

You may not qualify if:

  • \<18 years old
  • resides outside 5 county region
  • inability to consent or have legal proxy consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Cincinnati

Cincinnati, Ohio, 45267-0525, United States

Location

Related Publications (1)

  • Gillard PJ, Sucharew H, Kleindorfer D, Belagaje S, Varon S, Alwell K, Moomaw CJ, Woo D, Khatri P, Flaherty ML, Adeoye O, Ferioli S, Kissela B. The negative impact of spasticity on the health-related quality of life of stroke survivors: a longitudinal cohort study. Health Qual Life Outcomes. 2015 Sep 29;13:159. doi: 10.1186/s12955-015-0340-3.

Biospecimen

Retention: SAMPLES WITH DNA

We have collected blood and/or buccal samples from an interviewed cohort during years 1999,2005, and 2010.

MeSH Terms

Conditions

Ischemic StrokeHemorrhageStrokeIschemia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Brett M Kissela, MD

    University of Cincinnati

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

March 19, 2008

First Posted

March 24, 2008

Study Start

July 1, 1993

Primary Completion

June 30, 2025

Study Completion

June 30, 2025

Last Updated

September 24, 2024

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will share

we have a website: https://www.gcnkss.com where de-identified data can be requested via an approval process

Shared Documents
STUDY PROTOCOL
Time Frame
Current study data through 2015 is available via website. 2020 data will be available at a future date.
Access Criteria
please see website below
More information

Locations